Furthermore, we detected that the concentration of anti-inflammatory mediators, such as IL-1ra, and several chemokines, such as IL-7, IL-8, RANTES, MIP-1α, MIP-1β, and MCP-1, was significantly decreased in patients with MS (Padj < 0.05) (Figure 5). This evidence concerns the gene IL7 and myeloid sarcoma.